About Nanosens Innovations
Nanosens Innovations is a Healthcare company based in San Diego (United States) founded in 2006 by Kiana Aran and Michael Heltzen, and was acquired by Cardea Bio in October 2019. Nanosize biosensors are developed for biological sample analysis. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Biosensors. Its competitors include Nix, Cardea Bio and Hememics Biotechnologies; 3 of its 3 listed competitors have raised funding.
Company details
Nanosens Innovations was founded in 2006 in San Diego, United States, within the biotechnology sector. Biosensor assays are developed using the Cardea graphene technology platform to enable customized testing for omics, DNA, RNA, and protein samples. Proprietary bio-capturing methods based on graphene molecules are employed to capture and quantify biological compounds in various assays. Operations focus on signal-optimized solutions for research and diagnostic applications.
- Headquarters San Diego, United States
- Founders Kiana Aran, Michael Heltzen
- Stage Acquired
- SectorsHealthcare
- Website nanosens.com
- Social LinkedIn X YouTube
- Acquired by Cardea Bio (Oct 2019)
- Investors
- Acquired byCardea Bio
(Oct 2019)
Apps and channels of Nanosens Innovations
its YouTube channel Paragraf has 126 subscribers and 10 videos.
Videos from Nanosens Innovations
The most watched videos on Nanosens Innovations's YouTube channel, Paragraf (126 subscribers). Click a video to play it here.
More on Paragraf.
Investors in Nanosens Innovations
Nanosens Innovations has secured backing from 1 investor. Prominent investors backing the company include Cardea Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Digital graphene biosensors are developed using machine learning. | 2019 | cardeabio.com | San Diego, United States |
Investor details for Nanosens Innovations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nanosens Innovations
2 people are tracked at Nanosens Innovations (2 in leadership).
| Name | Role | Group |
|---|---|---|
Kiana Aran | Co-Founder & CTO | Leadership |
Michael Heltzen | Co-Founder | Leadership |
Complete people profiles for Nanosens Innovations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nanosens Innovations
2 dated milestones of Nanosens Innovations across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Nanosens Innovations is founded.
- Exit Acquired by Cardea Bio.
Competitors of Nanosens Innovations
Nanosens Innovations has 3 listed competitors in our database, 3 of them funded. They include Nix, Cardea Bio and Hememics Biotechnologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nixbiosensors.com | 2015 | Boston, United States | $6.95M | Sweat-based biosensors are provided for body hydration monitoring. | ||
| cardeabio.com | 2019 | San Diego, United States | $21.8M | Digital graphene biosensors are developed using machine learning. | ||
| hememics.com | 2009 | Gaithersburg, United States | $4.6M | 13 | Biopreservation platform for mammalian cells and biologics is developed. |
Detailed competitors of Nanosens Innovations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Nanosens Innovations (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanosens Innovations
Complete news archive for Nanosens Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanosens Innovations
Nanosens Innovations was founded in 2006.
Nanosens Innovations is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Nanosens Innovations was founded in 2006 in San Diego, United States, within the biotechnology sector. Biosensor assays are developed using the Cardea graphene technology platform to enable customized testing for omics, DNA, RNA, and protein samples. Proprietary bio-capturing methods based on graphene molecules are employed to capture and quantify biological compounds in various assays. Operations focus on signal-optimized solutions for research and diagnostic applications.
Nanosens Innovations's top competitors include Nix, Cardea Bio and Hememics Biotechnologies.
Nanosens Innovations has 1 investor. Key investors include Cardea Bio.
Yes. Nanosens Innovations was acquired by Cardea Bio in October 2019.